Hakoda M, Nishioka K, Kamatani N
Institute of Rheumatology, Tokyo Women's Medical College, Japan.
Cancer Res. 1990 Mar 15;50(6):1738-41.
Associations between germinal and somatic mutations at autosomal loci play an important role in the development of some tumors, including retinoblastoma. In an attempt to determine whether equivalent events occur in vivo at other loci, we cloned and enumerated somatic T-cells with mutations at the aprt locus, by taking advantage of both the presence of a human disease caused by genetic defects at this locus and an effective selection procedure for the deficient mutants. T-cells homozygously deficient at this locus (aprt-/-) were found in all four heterozygotes (aprt+/-) studied, at an average frequency of 1.3 x 10(-4). From 310 normal individuals, we identified only one aprt-/- clone, and the calculated frequency of aprt-/- T-cells in aprt+/+ individuals was 5.0 x 10(-9). These results confirm that a two-step process (aprt(+/+)----aprt(+/-)----aprt-/-) is functional through two different mechanisms (germinal-somatic and somatic-somatic) in vivo. Our data suggest that the two-step mutations leading to homozygous deficiencies at the somatic cell level, as proposed for the carcinogenic mechanisms for retinoblastomas and other human tumors, generally occur at rather high frequencies at various autosomal loci in humans.
常染色体位点上的胚系突变与体细胞突变之间的关联在包括视网膜母细胞瘤在内的一些肿瘤的发生发展中起着重要作用。为了确定在体内其他位点是否会发生类似事件,我们利用该位点的遗传缺陷所导致的一种人类疾病以及针对缺陷突变体的有效筛选程序,克隆并计数了在aprt位点发生突变的体细胞T细胞。在所研究的所有4名杂合子(aprt+/-)中均发现了该位点纯合缺陷的T细胞(aprt-/-),平均频率为1.3×10^(-4)。在310名正常个体中,我们仅鉴定出1个aprt-/-克隆,并且计算得出aprt+/+个体中aprt-/- T细胞的频率为5.0×10^(-9)。这些结果证实,一个两步过程(aprt(+/+)----aprt(+/-)----aprt-/-)通过两种不同机制(胚系-体细胞和体细胞-体细胞)在体内发挥作用。我们的数据表明,如视网膜母细胞瘤和其他人类肿瘤的致癌机制所提出的,导致体细胞水平纯合缺陷的两步突变,通常在人类各种常染色体位点以相当高的频率发生。